Mastoid cavity obliteration using bone pâté versus bioactive glass granules in the management of chronic otitis media (squamous disease): a prospective comparative study. Issue 6 (12th June 2021)

• Record Type: Journal Article
• Authors: Mishra, A K; Mallick, A; Galagali, J R; Gupta, A; Sethi, A; Ghotra, A
• Is Part Of: Journal of laryngology & otology. Volume 135:Issue 6(2021)
• Page Start: 492
• Page End: 500
• Publication Date: 2021-06-12
• Subjects: Otitis Media, -- Cholesteatoma, -- Mastoidectomy, -- Recidivism, -- Infection Control, -- Quality Of Life; Otolaryngology -- Periodicals; 617.51
• DOI: 10.1017/S0022215121001195
• Languages: English
• ISSNs: 0022-2151

Abstract

Abstract: Objective: To compare the efficacy of bone pâté versus bioactive glass in mastoid obliteration. Method: This randomised parallel groups study was conducted at a tertiary care centre between September 2017 and August 2019. Sixty-eight patients, 33 males and 35 females, aged 12–56 years, randomly underwent single-stage canal wall down mastoidectomy with mastoid obliteration using either bone pâté ( n = 35) or bioactive glass ( n = 33), and were evaluated 12 months after the operation. Results: A dry epithelised cavity (Merchant's grade 0 or 1) was achieved in 65 patients (95.59 per cent). Three patients (4.41 per cent) showed recidivism. The mean air–bone gap decreased to 16.80 ± 4.23 dB from 35.10 ± 5.21 dB pre-operatively. The mean Glasgow Benefit Inventory score was 30.02 ± 8.23. There was no significant difference between the two groups in these outcomes. However, the duration of surgery was shorter in the bioactive glass group (156.87 ± 7.83 vs 162.28 ± 8.74 minutes; p = 0.01). Conclusion: The efficacy of both materials was comparable.